The Serum Institute of India (SII) on Thursday applied to the Drug Controller General of India (DCGI) seeking permission for a test license to manufacture Russia's Sputnik V COVID-19 vaccine.
Further details awaited.
Advertisement
(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)